The Optimized Omega-3 EPA:DHA 6:1 Product Prevents the Monocrotaline-Induced Pulmonary Arterial Hypertension, Vascular Remodeling and Endothelial Dysfunction in Rats

被引：0

作者：

Schini-Kerth, Valerie ^{[1
]}

Said, Amissi ^{[1
]}

Niazi, Zahid Rasul ^{[1
]}

Melanie, Burban ^{[1
]}

Kessler, Romain ^{[1
]}

Canuet, Mathieu ^{[1
]}

Toti, Florence ^{[1
]}

Monassier, Laurent ^{[1
]}

Boehm, Nelly ^{[1
]}

Auger, Cyril ^{[1
]}

Meziani, Ferhat ^{[1
]}

机构：

[1] Strasbourg Univ, Fac Pharm, Illkirch Graffenstaden, France

来源：

JOURNAL OF VASCULAR RESEARCH | 2016年 / 53卷

关键词：

D O I：

暂无

中图分类号：

Q4 [生理学];

学科分类号：

071003 ;

摘要：

引用

页码：7 / 7

页数：1

共 50 条

[1] The optimized omega-3 EPA:DHA 6:1 product prevents the monocrotaline-induced pulmonary hypertension, right ventricular hypertrophy, pulmonary endothelial dysfunction and vascular remodeling in rats
Amissi, S.
Niazi, Z. R.
Burban, M.
Kessler, R.
Canuet, M.
Toti, F.
Monassier, L.
Boehm, N.
Auger, C.
Meziani, F.
Schini-Kerth, V. B.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 : 14 - 14
[2] The omega-3 EPA:DHA 6:1 formulation prevents the monocrotaline-induced pulmonary hypertension, pulmonary artery remodelling, endothelial dysfunction, and right ventricular failure in rats
Said, Amissi
Niazi, Zahid R.
Burban, Melanie
Kessler, Romain
Canuet, Mathieu
Toti, Florence
Monassier, Laurent
Boehm, Nelly
Auger, Cyril
Meziani, Ferhat
Schini-Kerth, Valerie B.
BIOCHEMICAL PHARMACOLOGY, 2017, 139 : 122 - 123
[3] Dihydromyricetin prevents monocrotaline-induced pulmonary arterial hypertension in rats
Li, Qinghai
Wang, Jun
Zhu, Xianying
Zeng, Zhilin
Wu, Xiaomei
Xu, Yongjian
Xie, Jungang
Yu, Jun
BIOMEDICINE & PHARMACOTHERAPY, 2017, 96 : 825 - 833
[4] Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
Tong, Yi
Jiao, Qian
Liu, Yuanru
Lv, Jiankun
Wang, Rui
Zhu, Lili
FRONTIERS IN PHARMACOLOGY, 2018, 9
[5] Arctigenin prevents monocrotaline-induced pulmonary arterial hypertension in rats
Jiang, Wei-Long
Han, Xiao
Zhang, Yu-Feng
Xia, Qing-Qing
Zhang, Jia-Ming
Wang, Feng
RSC ADVANCES, 2019, 9 (01) : 552 - 559
[6] 3-Bromopyruvate prevents monocrotaline-induced pulmonary arterial hypertension in rats
Zhang Rui
Sun Xiaoqing
Zhang Hongda
Liu Jinming
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C16 - C16
[7] Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats
Shi, Ruizan
Wei, Zehui
Zhu, Diying
Fu, Naijie
Wang, Chang
Yin, Sha
Liang, Yueqin
Xing, Jianfeng
Wang, Xuening
Wang, Yan
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 : 124 - 135
[8] 3-Bromopyruvate Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension In Rats
Zhang, R.
Qiu, M. -H.
Zhang, H. -D.
Sun, X. -Q.
Liu, J. -M.
Jing, Z. -C.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
[9] Formononetin attenuates monocrotaline-induced pulmonary arterial hypertension via inhibiting pulmonary vascular remodeling in rats
Cai, Changhong
Xiang, Yijia
Wu, Yonghui
Zhu, Ning
Zhao, Huan
Xu, Jian
Lin, Wensheng
Zeng, Chunlai
MOLECULAR MEDICINE REPORTS, 2019, 20 (06) : 4984 - 4992
[10] Compound xiebai capsule alleviates pulmonary vascular remodeling in monocrotaline-induced pulmonary arterial hypertension in rats
Wu, Zhouye
Xi, Zhaoqing
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2020, 19 (01) : 107 - 114

← 1 2 3 4 5 →